356 related articles for article (PubMed ID: 16133135)
1. Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain.
Pedersen LH; Nielsen AN; Blackburn-Munro G
Psychopharmacology (Berl); 2005 Nov; 182(4):551-61. PubMed ID: 16133135
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.
Rode F; Broløs T; Blackburn-Munro G; Bjerrum OJ
Psychopharmacology (Berl); 2006 Aug; 187(3):364-75. PubMed ID: 16783541
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
[TBL] [Abstract][Full Text] [Related]
4. Topical gabapentin gel alleviates allodynia and hyperalgesia in the chronic sciatic nerve constriction injury neuropathic pain model.
Shahid M; Subhan F; Ahmad N; Ali G; Akbar S; Fawad K; Sewell RD
Eur J Pain; 2017 Apr; 21(4):668-680. PubMed ID: 27862616
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.
Bomholt SF; Mikkelsen JD; Blackburn-Munro G
Neuropharmacology; 2005 Feb; 48(2):252-63. PubMed ID: 15695164
[TBL] [Abstract][Full Text] [Related]
6. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
[TBL] [Abstract][Full Text] [Related]
7. Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion.
Jesse CR; Wilhelm EA; Nogueira CW
Psychopharmacology (Berl); 2010 Dec; 212(4):513-22. PubMed ID: 20689938
[TBL] [Abstract][Full Text] [Related]
8. A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.
Wu WP; Hao JX; Ongini E; Impagnatiello F; Presotto C; Wiesenfeld-Hallin Z; Xu XJ
Br J Pharmacol; 2004 Jan; 141(1):65-74. PubMed ID: 14662726
[TBL] [Abstract][Full Text] [Related]
9. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain.
Erichsen HK; Hao JX; Xu XJ; Blackburn-Munro G
Pain; 2005 Aug; 116(3):347-358. PubMed ID: 15982817
[TBL] [Abstract][Full Text] [Related]
10. Multiplicative interactions to enhance gabapentin to treat neuropathic pain.
Hayashida K; Eisenach JC
Eur J Pharmacol; 2008 Nov; 598(1-3):21-6. PubMed ID: 18822281
[TBL] [Abstract][Full Text] [Related]
11. The antinociceptive effect of SNAP5114, a gamma-aminobutyric acid transporter-3 inhibitor, in rat experimental pain models.
Kataoka K; Hara K; Haranishi Y; Terada T; Sata T
Anesth Analg; 2013 May; 116(5):1162-1169. PubMed ID: 23456665
[TBL] [Abstract][Full Text] [Related]
12. The antihyperalgesic effects of intrathecal bupropion, a dopamine and noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
Hoshino H; Obata H; Nakajima K; Mieda R; Saito S
Anesth Analg; 2015 Feb; 120(2):460-6. PubMed ID: 25427287
[TBL] [Abstract][Full Text] [Related]
13. The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.
Munro G; Storm A; Hansen MK; Dyhr H; Marcher L; Erichsen HK; Sheykhzade M
Pharmacol Biochem Behav; 2012 May; 101(3):465-78. PubMed ID: 22366217
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain.
Coderre TJ; Kumar N; Lefebvre CD; Yu JS
J Neurochem; 2007 Mar; 100(5):1289-99. PubMed ID: 17241130
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states.
Boroujerdi A; Zeng J; Sharp K; Kim D; Steward O; Luo DZ
Pain; 2011 Mar; 152(3):649-655. PubMed ID: 21239111
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the analgesic effects of ammoxetine, a novel potent serotonin and norepinephrine reuptake inhibitor.
Zhang TT; Xue R; Zhu L; Li J; Fan QY; Zhong BH; Li YF; Ye CY; Zhang YZ
Acta Pharmacol Sin; 2016 Sep; 37(9):1154-65. PubMed ID: 27424654
[TBL] [Abstract][Full Text] [Related]
17. An Improved Rodent Model of Trigeminal Neuropathic Pain by Unilateral Chronic Constriction Injury of Distal Infraorbital Nerve.
Ding W; You Z; Shen S; Yang J; Lim G; Doheny JT; Chen L; Zhu S; Mao J
J Pain; 2017 Aug; 18(8):899-907. PubMed ID: 28238950
[TBL] [Abstract][Full Text] [Related]
18. Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models.
Christoph T; Kögel B; Strassburger W; Schug SA
Drugs R D; 2007; 8(1):51-7. PubMed ID: 17249849
[TBL] [Abstract][Full Text] [Related]
19. Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.
Yalcin I; Tessier LH; Petit-Demoulière N; Doridot S; Hein L; Freund-Mercier MJ; Barrot M
Neurobiol Dis; 2009 Mar; 33(3):386-94. PubMed ID: 19084064
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.
Rodrigues-Filho R; Campos MM; Ferreira J; Santos AR; Bertelli JA; Calixto JB
Brain Res; 2004 Aug; 1018(2):159-70. PubMed ID: 15276874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
